Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib/IIa Study to Evaluate the Safety and Efficacy of Intravitreal Administration of Two Doses of BAT5906 Injection With Multiple Dosing Regimens in Patients With Diabetic Macular Edema

NCT04772105 is registered in ClinicalTrials.gov with Bio-Thera Solutions as lead sponsor.

NCT NCT04772105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04772105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib/IIa Study to Evaluate the Safety and Efficacy of Intravitreal Administration of Two Doses of BAT5906 Injection With Multiple Dosing Regimens in Patients With Diabetic Macular Edema
Lead sponsor
Bio-Thera Solutions
Phase
Phase 1/2
Overall status
Completed
Start date
October 16, 2020
Completion date
November 6, 2023
Enrollment
60 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema